SLN-548

N/A

Report date: 2025/03/10 14:25:02
NME

Base Information

Drug NameSLN-548
Drug Alias NameSLN548SLN-548
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsComplement-Mediated Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSilence Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesSilence Therapeutics Plc
Inactive CompaniesN/A
Active IndicationsComplement-Mediated Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A